ProKidney Corp (NAS:PROK)
$ 2.38 -0.02 (-0.83%) Market Cap: 300.00 Mil Enterprise Value: -123.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

ProKidney Corp at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 04:15PM GMT
Release Date Price: $8.35 (+3.73%)
Vikram Purohit
Morgan Stanley - Analyst

Okay. Welcome, everyone. Let's go ahead and get started. And this is the fireside chat with ProKidney. My name is Vikram Purohit, I'm one of the biotech analysts with the research team. Before we get started, I need to read a brief disclosure statement for important disclosures. Please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

With that, happy to have with me Tim Bertram, CEO ProKidney. Tim, thanks for joining us.

Questions & Answers

Tim Bertram
ProKidney Corp. - CEO

Yeah. Look forward to it.

Vikram Purohit
Morgan Stanley - Analyst

Tim, maybe just to level set for everyone in the audience, could you just quickly walk us through the REACT technology, what it is, the thesis that drove the formation of ProKidney, and then

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot